GC Therapeutics

Cambridge, MA · Founded 2019 · Privately Held (backing)

Developer of a genome-wide cell programming platform designed to convert patient-derived stem cells into multiple cell types. GC Therapeutics is based in Cambridge, MA and was founded in 2019. Its last known valuation is $135 million. It has raised $74.7 million.

Last price · $/share

—

Implied valuation

$135.0M

Total raised

$74.7M

Last round

—

How much has GC Therapeutics raised?

$74.7Macross 0 recorded rounds

Free account

More of GC Therapeutics with a free account

·The complete investor list: 14 names
·Watch GC Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

GC Therapeutics investors

14 investors are on record for GC Therapeutics, including Alumni Ventures, Andreessen Horowitz, Global Brain and Gaingels. By type, the record holds 8 venture capital firms and 1 asset manager.

For fundraisers

Raising for a company like GC Therapeutics?

14 investors have backed GC Therapeutics.

See all 14 investors →

Frequently asked about GC Therapeutics

How much has GC Therapeutics raised?: GC Therapeutics has raised $74.7M in total across 0 recorded funding rounds.